Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
{{output}}
Skeletal metastasis occurs in around 75% of advanced breast cancers, with the disease incurable once cancer cells disseminate to bone, but there remains an unmet need for biomarkers to identify patients at high risk of bone recurrence. This study aimed to iden... ...
